Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression

Bone marrow (BM) fibrosis is an adverse prognostic marker in several myeloid neoplasms, particularly in myelodysplastic syndrome (MDS) with fibrosis; however, its significance in chronic myelomonoctyic leukemia (CMML) has not been evaluated. We performed a retrospective analysis to investigate the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova-Drus, Kseniya, Chiu, April, Margolskee, Elizabeth, Barouk-Fox, Sharon, Geyer, Julia, Dogan, Ahmet, Orazi, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732726/
https://www.ncbi.nlm.nih.gov/pubmed/29262560
http://dx.doi.org/10.18632/oncotarget.21870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732726/
https://www.ncbi.nlm.nih.gov/pubmed/29262560
http://dx.doi.org/10.18632/oncotarget.21870

Ejemplares similares